The FDA is citing new evidence that problematic use and overdose risk go up when taking opioid analgesics for long-term pain ...

Powered by the Databricks Data Intelligence Platform and backed by their innovative engineering teams, Tevogen.AI has begun curating a dataset focused on oncology. The dataset, aggregated with the ...

The Seized Drug Suite's DART-HRMS workflow accelerates drug analysis, ensuring rapid identification of substances and ...

As Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...

A thing takes place, and it goes into the history books. But whether something even gets remembered and how is often far from ...

Total revenue for the three months ended June 30, 2025 increased by $1.5 million as compared to the three months ended June 30, 2024, primarily as a result of increases in Incyte revenue of $1.5 ...

Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 and an expected submission of a Biologic License Application (BLA) in the ...

Amneal Pharmaceuticals, Inc. ( NASDAQ: AMRX) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET ...